GlassScriptPhysician profile
James C Tucker
NPI 1942228150
$6,497.20
in general payments reported to CMS, 2019-2025
66 companies · $1,401 in 2025
The $1,401 reported for 2025 was more than what 87% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $606 · 2021: $873 · 2022: $918 · 2023: $1,044 · 2024: $1,191 · 2025: $1,401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,635.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $522.85 | 2019-2025 | Opdivo, Krazati, Augtyro |
| Astrazeneca Pharmaceuticals LP | $521.06 | 2019-2025 | Imfinzi, Lynparza, Calquence |
| Novartis Pharmaceuticals Corporation | $434.00 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $327.79 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Eisai INC. | $296.94 | 2019-2025 | |
| Incyte Corporation | $276.16 | 2020-2025 | Jakafi, Pemazyre, Monjuvi |
| Janssen Biotech, INC. | $233.08 | 2019-2025 | Talvey, Darzalex, Tecvayli |
| Seagen INC. | $211.00 | 2019-2023 | Tukysa, Padcev, Adcetris |
| Genzyme Corporation | $197.31 | 2020-2025 | |
| Celgene Corporation | $194.14 | 2019-2025 | Reblozyl, Opdualag |
| Amgen INC. | $191.84 | 2019-2023 | Lumakras |
| Abbvie INC. | $184.69 | 2021-2025 | Venclexta |
| Bayer Healthcare Pharmaceuticals INC. | $184.15 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $179.71 | 2019-2025 | Libtayo, Lynozyfic |
| Alexion Pharmaceuticals, INC. | $134.63 | 2024-2025 | Ultomiris |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beone Medicines USA, INC. | $126.52 | 2025 | Brukinsa, Tevimbra |
| Exelixis INC. | $122.14 | 2019-2025 | Cabometyx |
| Lilly USA, LLC | $114.42 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Myriad Genetic Laboratories, INC. | $106.24 | 2021-2024 | Bracanalysis Cdx |
| Stemline Therapeutics INC. | $103.50 | 2023-2024 | Orserdu |
| Sun Pharmaceutical Industries INC. | $103.01 | 2023-2024 | Yonsa, Odomzo |
| Takeda Pharmaceuticals U.S.A., INC. | $98.76 | 2019-2023 | Ninlaro, Iclusig |
| Genentech USA, INC. | $97.73 | 2019-2025 | Tecentriq, Tecentriq Hybreza |
| Pharmacyclics LLC, An Abbvie Company | $95.43 | 2019-2023 | Imbruvica |
| Ipsen Biopharmaceuticals, INC | $85.87 | 2019-2024 | Somatuline Depot, Onivyde |
| Karyopharm Therapeutics INC. | $81.24 | 2021-2023 | Xpovio |
| Rigel Pharmaceuticals, INC. | $72.14 | 2023-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Servier Pharmaceuticals LLC | $66.31 | 2023-2025 | |
| Dova Pharmaceuticals | $64.93 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.57 | 2023-2024 | Gilotrif |
| Aveo Pharmaceuticals, INC. | $53.91 | 2022-2024 | Fotivda |
| Blueprint Medicines Corporation | $50.86 | 2022-2024 | Ayvakit |
| Janssen Pharmaceuticals, INC | $44.90 | 2019-2024 | Xarelto |
| Pharmaessentia USA Corporation | $44.64 | 2025 | Besremi |
| Myovant Sciences INC. | $44.57 | 2021-2022 | |
| Novocure INC. | $42.07 | 2020-2025 | Optune Lua (Novottf-200t) |
| Puma Biotechnology, INC. | $41.58 | 2020-2025 | |
| Daiichi Sankyo INC. | $39.35 | 2024-2025 | Enhertu |
| Coherus Oncology, INC. | $39.05 | 2024-2025 | Loqtorzi |
| Genmab U.S., INC. | $38.34 | 2025 | Epkinly |
| Jazz Pharmaceuticals INC. | $35.37 | 2019-2022 | |
| Adc Therapeutics America, INC. | $35.17 | 2022 | |
| Glaxosmithkline, LLC. | $34.22 | 2023-2025 | Ojjaara, Blenrep, Shingrix |
| Sumitomo Pharma America, INC. | $32.34 | 2023 | Orgovyx |
| Astellas Pharma US INC | $31.22 | 2020-2024 | Padcev |
| Pfizer INC. | $28.28 | 2019-2021 | |
| Geron Corporation | $27.21 | 2025 | Rytelo |
| Siemens Medical Solutions USA, INC. | $25.42 | 2024 | Aria Radiation Therapy Management Software |
| Acceleron Pharma, INC. | $24.34 | 2020 | |
| Amag Pharmaceuticals, INC. | $24.18 | 2021 | |
| Adaptive Biotechnologies Corporation | $22.62 | 2024 | Clonoseq |
| Fennec Pharmaceuticals, INC. | $22.60 | 2025 | Fyarro |
| Boston Scientific Corporation | $22.43 | 2024 | Spaceoar Vue System - 10ml |
| Tolmar Pharmaceuticals, INC. | $20.62 | 2022 | |
| Kyowa Kirin, INC. | $20.48 | 2025 | |
| Deciphera Pharmaceuticals INC. | $18.18 | 2021 | |
| Emd Serono, INC. | $17.91 | 2024 | |
| Kite Pharma, INC. | $17.07 | 2021 | |
| Global Blood Therapeutics, INC. | $16.84 | 2020 | |
| Progenics Pharmaceuticals, INC. | $16.77 | 2025 | |
| Acrotech Biopharma INC. | $15.97 | 2025 | Beleodaq |
| Beigene USA, INC. | $14.04 | 2023 | Brukinsa |
| Array Biopharma INC | $13.72 | 2021 | |
| Taiho Oncology, INC. | $13.52 | 2019 | |
| Secura Bio, INC. | $12.84 | 2020 | |
| Agios Pharmaceuticals, INC. | $12.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.